The UM-HMC series, encompassing UM-HMC-1, UM-HMC-3B, and UM-HMC-3A, are pioneering cell lines derived from human salivary mucoepidermoid carcinomas, pivotal for advancing research in oncology and cellular biology. Originating from a primary tumor (UM-HMC-1) and its recurrence and lymph node metastasis (UM-HMC-3A and UM-HMC-3B, respectively), these cell lines have been instrumental in characterizing the tumorigenic potential and cancer stem cell properties within salivary gland carcinomas. Studies utilizing these cell lines have shed light on critical aspects of cancer biology, including the role of ALDH/CD44 in identifying tumorigenic cancer stem cells, the necessity of mTOR signaling for the survival of these cancer stem cells, and the influence of p53 in regulating Bmi-1-driven self-renewal and stemness. As such, the UM-HMC series represents a valuable resource for researchers aiming to explore the molecular mechanisms underlying salivary gland cancer progression, metastasis, and treatment resistance, thereby offering potential pathways for developing targeted therapies.Complete list of cell lines from this panel:?at. T8160 - Human Mucoepidermoid Carcinoma Cell Line (UM-HMC-3A)Cat.?8161 - Human Mucoepidermoid Carcinoma Cell Line (UM-HMC-3B) Cat.?8173 - Human Mucoepidermoid Carcinoma Cell Line (UM-HMC-1)
Cell Type
Tumor Cells
Biosafety Level
2
Depositor
University of Michigan
Disclaimer
1. All test parameters provided in the CoA are conducted using abm's standardized culture system and procedures. The stated values may vary under the end-user's culture conditions. Please verify that the product is suitable for your studies by referencing published papers or ordering RNA (0.5 ?g, Cat.# C207, $450.00) or cell lysate (100 ?g, Cat.# C206, $600.00) to perform preliminary experiments, or alternatively use our Gene Expression Assay Service (Cat# C138). All sales are final. 2. We recommend live cell shipments for ease of cell transfer and this option can be requested at the time of ordering. Please note that the end-user will need to evaluate the feasibility of live cell shipment by taking into account the final destination's temperature variation and its geographical location. In addition, we thoroughly test our cell lines for freeze-thaw recovery. If frozen cells were received and not recovered in your lab under the exact, specified conditions (using recommended culture vessel, media, additional supplements, and atmospheric conditions), a live cell replacement is possible at a cost (plus shipping). 3. All of abm's cell biology products are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its cell biology product(s) in therapeutic/diagnostic application(s). Please contact a technical service representative for more information. 4. abm makes no warranties or representations as to the accuracy of the information on this site. Citations from literature and provided for informational purposes only. abm does not warrant that such information has been shown to be accurate. 5. abm warrants that cell lines shall be viable upon initiation of culture for a period of thirty (30) days after shipment and that they shall meet the specifications on the applicable abm Material Product Information sheet, certificate of analysis, and/or catalog description. Such thirty (30) day period is referred to herein as the "Warranty Period."
Donor History
Female, 73, Caucasian, , Left hard palate (local recurrence = 3A cell line) and lymph node metastasis (=3B cell line), T4BN, stage IVb, intermediate grade, + for both perineural and angio-lymphatic invasion.
Growth Properties
Adherent, epithelial
Growth Conditions
PriCoat?T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture.?riGrow III (TM003) + 10% FBS +?% L-glutamine (G275) + 400 ng/ml hydrocortisone (TM066)? 20 ng/ml rhEGF (Z100139)? 5 ug/ml recombinant human Insulin (Z101065)? 1% Penicillin/Streptomycin Solution (G255), 37.0?, 5% CO?.Note: re-suspend cells well at each stage (thawing, post-centrifugation etc.) as cells have a tendency to clump. Freeze-thaw viability for this cell line varies. For best results, seed thawed cells, collect floating cells the next day, centrifuge and re-plate into a new flask.
Tissue
Salivary Gland
Notes
1. Visually examine the packaging containers for signs of leakage or breakage. 2. Immediately transfer frozen cells from dry ice packaging to a temperature below -130?, preferably in liquid nitrogen vapor phase storage, until ready for use.To ensure the highest level of viability, thaw the vial and initiate culture as soon as possible upon receipt. If continued storage is desired, the vial should only be stored below -130? or in liquid nitrogen vapor phase. Do not store at -70?, as it will result in loss of viability.
Organism
Human (H. sapiens)
Cryopreservation
Cryopreservation Medium (TM024), or complete growth media with 10% DMSO.
Applications Range
Research Use Only.
Shipping
Ship with dry ice.
Product Format
Frozen
Product Use
This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
Storage
Vapor phase of liquid nitrogen, or below -130?.
Thawing Protocol
1. Thaw cells quickly in a 37? water bath while agitating gently (maximum 2 minutes). The vial cap should be kept above the water level to minimize the risk of contamination. 2. Decontaminate the vial by spraying and wiping the exterior of the vial with 70% ethanol. From this point onwards, all operations should be strictly carried out inside a biological safety cabinet using aseptic conditions. 3. Transfer the cell suspension into a 15ml sterile conical tube containing 5ml of pre-warmed, complete growth media. Pipette up and down several times to beak up clumps. Centrifuge cells at 800 RPM for 5-7 minutes. 4. Aspirate the supernatant without disturbing the cell pellet. Re-suspend the cell pellet in the recommended pre-warmed, complete growth media and dispense into a T25 culture flask. 5. Incubate the cells at the recommended conditions.
Subculture Protocol
Volumes given below are for a T75 flask; proportionally increase or decrease the volume as required per culture vessel size. Subculture cells once the culture vessel is 80% confluent. 1. Aspirate the culture media, gently wash adherent layer with 1X PBS 2-3 times, and add 2-3ml of pre-warmed 0.25% Trypsin-EDTA to the culture vessel. 2. Observe the cells under a microscope to confirm detachment (typically within 5-10 minutes). Cells that are difficult to detach can be put in 37?, for several minutes to facilitate detachment.?br>3. Neutralize Trypsin-EDTA by adding an equal volume of the complete growth media into the culture vessel. 4. Transfer the culture suspension into a sterile centrifuge tube, and centrifuge at 800 RPM for 5 minutes. The actual centrifuge duration and speed may vary depending on the cell type. 5. Aspirate the supernatant, and re-suspend the pellet with pre-warmed fresh complete growth media. Add appropriate aliquots of the cell suspension to new culture vessels, as desired. 6. Incubate the cells at the recommended conditions.
Reviews of Human Mucoepidermoid Carcinoma Cell Line (UM-HMC-3A)